AstraZeneca (AZN) Rare Disease, Alexion and Merck (MRK) announced positive topline results from the Phase 3 KOMET trial, a Phase 3 trial in adults with neurofibromatosis type 1 – NF1 – who have ...
Ginkgo Bioworks (DNA) completed the first milestone of a partnership with Merck (MRK) focused on improving biologic manufacturing. As part of ...
German sci-tech giant Merck is very optimistic about its prospects in the Chinese market and will continue to strengthen its ...
The company's platform integrates clinical and molecular data into personalized treatment plans for patients. The company has ...
Leidos has announced a partnership with the University of Edinburgh in the United Kingdom to advance AI and data science solutions. The partnership will leverage the university's Bayes Centre, an ...
Dublin, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The "Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 ...
Zymo Research Corporation (Zymo Research), a leader in innovative life science solutions, announced today that it has filed claims in the United ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback